Quantification of Core Antigen Monitors Efficacy of Combination Therapy of Sofosbuvir, Daclatasvir and Ribavirin in Egyptian Cirrhotic Patients with HCV Infection as an Alternative to PCR

Afnan Helmy Hassan Ahmed Baraka;

Abstract


ABSTRACT
Background:. Hepatitis C virus (HCV) is a major public health problem throughout the world. Acute HCV infection is asymptomatic in most cases, and only 15% of cases are symptomatic,but Chronic hepatitis C (CHC) shows a variable clinical course, ranging from mild histopathological changes to active hepatitis and the development of hepatic fibrosis, cirrhosis and HCC. The aim of this work is to detect accuracy of core antigen in Egyptian cirrhotic patients with HCV Infection treated with combination therapy of Sofosbuvir, Daclatasvir and Ribavirin as an alternative to PCR.


Other data

Title Quantification of Core Antigen Monitors Efficacy of Combination Therapy of Sofosbuvir, Daclatasvir and Ribavirin in Egyptian Cirrhotic Patients with HCV Infection as an Alternative to PCR
Other Titles القياس الكمي لفاعلية رصد المستضد اللبي لمزيج العلاج بعقار سوفوسبوفير وداكلاتاسفير وريبافيرين في المرضى الذين يعانون من تليف الكبد المصابين بعدوى الالتهاب الفيروسي الكبدي سي كبديل لتفاعل البلمرة المتسلسل
Authors Afnan Helmy Hassan Ahmed Baraka
Issue Date 2019

Attached Files

File SizeFormat
J9474.pdf459.69 kBAdobe PDFView/Open
Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check

views 1 in Shams Scholar


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.